Sunho Biologics Inc (2898.HK)

HKD 4.04

(0.0%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021
Revenue 208 Thousand 1.73 Million 3.21 Million
Cost of Revenue 70 Thousand 1.25 Million -
Gross Profit 138 Thousand 473 Thousand 3.21 Million
Operating Expenses 138 Thousand 46.68 Million 69.83 Million
Selling, General and Administrative Expenses 40.7 Million 5.55 Million 5.79 Million
Research and Development Expenses 43.04 Million 53.17 Million 64.03 Million
Other Expenses - 8000.00 -
Cost and Expenses 83.74 Million 47.93 Million 69.83 Million
Operating Income -71.07 Million -46.15 Million -66.61 Million
Interest Expense 692 Thousand 5.07 Million -
Income Tax Expense - - -
Earnings before Tax -132.7 Million -51.98 Million -70.63 Million
Net Income -132.7 Million -51.98 Million -70.63 Million
Earnings Per Share Basic -1.43 -0.57 -0.78
Earnings Per Share Diluted -1.43 -0.57 -0.78
Weighted Average Shares Outstanding 92.88 Million 91.2 Million 91 Million
Weighted Average Shares Outstanding (Diluted) 92.88 Million 91.2 Million 91 Million
Gross Margin 0.66 0.27 1.00
EBIT Margin -593.12 -21.58 -19.97
Profit Margin -637.99 -30.03 -21.96
EBITDA -123.36 Million -38.1 Million -64.21 Million
Earnings Before Tax Margin -341.72 -26.66 -20.71

Income Statement Charts